JP2009536193A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009536193A5 JP2009536193A5 JP2009509455A JP2009509455A JP2009536193A5 JP 2009536193 A5 JP2009536193 A5 JP 2009536193A5 JP 2009509455 A JP2009509455 A JP 2009509455A JP 2009509455 A JP2009509455 A JP 2009509455A JP 2009536193 A5 JP2009536193 A5 JP 2009536193A5
- Authority
- JP
- Japan
- Prior art keywords
- active ingredient
- nicotine
- precursor
- derivative
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- SNICXCGAKADSCV-JTQLQIEISA-N Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims 8
- 229960002715 Nicotine Drugs 0.000 claims 8
- 239000004480 active ingredient Substances 0.000 claims 8
- 229930015196 nicotine Natural products 0.000 claims 8
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims 4
- 239000000411 inducer Substances 0.000 claims 3
- 230000000202 analgesic Effects 0.000 claims 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims 2
- 229940121363 anti-inflammatory agents Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 101700074108 MLA Proteins 0.000 claims 1
- 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 claims 1
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 claims 1
- 210000003635 Pituitary Gland Anatomy 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-MSH Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 claims 1
Claims (8)
- 脳下垂体の中葉部に位置するメラニン細胞刺激ホルモン産生細胞からのα−ＭＳＨの放出の誘発の誘導剤であって、ニコチン、そのアナログ、その前駆体、またはその誘導体を有効成分として含有する、誘導剤。
- 有効成分としてニコチンを含有する、請求項１に記載の誘導剤。
- ニコチン、そのアナログ、その前駆体、またはその誘導体を有効成分として含有する、鎮痛剤。
- 有効成分としてニコチンを含有する、請求項３に記載の鎮痛剤。
- ニコチン、そのアナログ、その前駆体、またはその誘導体を有効成分として含有する、敗血症の治療剤。
- 有効成分としてニコチンを含有する、請求項５に記載の治療剤。
- ニコチン、そのアナログ、その前駆体、またはその誘導体を有効成分として含有する、抗炎症剤。
- 有効成分としてニコチンを含有する、請求項７に記載の抗炎症剤。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/MX2006/000031 WO2007129879A1 (es) | 2006-05-08 | 2006-05-08 | EL USO DE LA NICOTINA, SUS ANÁLOGOS, SUS PRECURSORES O SUS DERIVADOS EN EL TRATAMIENTO DE DIVERSOS PROCESOS PATOLÓGICOS SUSCEPTIBLES DE MEJORAR CON α-MSH ADMINISTRADA EN FORMA PROFILÁCTICA O TERAPÉUTICA. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009536193A JP2009536193A (ja) | 2009-10-08 |
| JP2009536193A5 true JP2009536193A5 (ja) | 2011-03-24 |
Family
ID=38667940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009509455A Pending JP2009536193A (ja) | 2006-05-08 | 2006-05-08 | 予防若しくは治療の形態で投与されるα−ＭＳＨを用いた、改善の余地のある多様な病理学的過程に関する治療におけるニコチン、そのアナログ、その前駆体またはその誘導体の使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US20090197921A1 (ja) |
| EP (4) | EP2801359A3 (ja) |
| JP (1) | JP2009536193A (ja) |
| KR (1) | KR20130116374A (ja) |
| CN (1) | CN101437515B (ja) |
| AU (1) | AU2006343439B2 (ja) |
| BR (1) | BRPI0621650A2 (ja) |
| CA (1) | CA2651580C (ja) |
| DK (1) | DK2801360T3 (ja) |
| ES (1) | ES2683323T3 (ja) |
| MX (1) | MX2008011473A (ja) |
| NZ (1) | NZ572366A (ja) |
| WO (1) | WO2007129879A1 (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8039459B2 (en) | 2004-07-15 | 2011-10-18 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
| US8557804B2 (en) | 2002-03-25 | 2013-10-15 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
| US20110206642A1 (en) * | 2009-10-15 | 2011-08-25 | Cohava Gelber | Preventing obesity-related metabolic syndrome with melagonesis |
| US9668969B1 (en) | 2012-02-22 | 2017-06-06 | Arturo Solis Herrera | Methods of using QIAPINE |
| EP3190887B1 (en) | 2014-09-09 | 2020-12-09 | Arturo Solis Herrera | Methods for treating and preventing ocular diseases, disorders, and conditions with melanin |
| US10639300B2 (en) | 2016-04-12 | 2020-05-05 | Arturo Solis Herrera | Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists |
| LU101520B1 (en) * | 2019-12-02 | 2021-06-07 | Herrera Arturo Solis | (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a homogeneous, viscous, semi-solid topical medication and topical medication |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030185761A1 (en) * | 1997-10-01 | 2003-10-02 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| US6610713B2 (en) * | 2000-05-23 | 2003-08-26 | North Shore - Long Island Jewish Research Institute | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| CA2341952A1 (en) * | 2001-03-23 | 2002-09-23 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases |
| SE0104388D0 (sv) * | 2001-12-27 | 2001-12-27 | Pharmacia Ab | New formulation and use and manufacture thereof |
| JP2007530586A (ja) * | 2004-03-25 | 2007-11-01 | ザ ファインスタイン インスティテュート フォー メディカル リサーチ | 神経性止血法 |
-
2006
- 2006-05-08 WO PCT/MX2006/000031 patent/WO2007129879A1/es active Application Filing
- 2006-05-08 KR KR1020137025038A patent/KR20130116374A/ko not_active Application Discontinuation
- 2006-05-08 BR BRPI0621650-1A patent/BRPI0621650A2/pt not_active Application Discontinuation
- 2006-05-08 DK DK14170573.1T patent/DK2801360T3/en active
- 2006-05-08 CA CA2651580A patent/CA2651580C/en active Active
- 2006-05-08 EP EP20140170572 patent/EP2801359A3/en not_active Withdrawn
- 2006-05-08 AU AU2006343439A patent/AU2006343439B2/en active Active
- 2006-05-08 NZ NZ572366A patent/NZ572366A/en not_active IP Right Cessation
- 2006-05-08 EP EP14170571.5A patent/EP2801358A3/en not_active Withdrawn
- 2006-05-08 ES ES14170573.1T patent/ES2683323T3/es active Active
- 2006-05-08 CN CN200680054519.1A patent/CN101437515B/zh active Active
- 2006-05-08 JP JP2009509455A patent/JP2009536193A/ja active Pending
- 2006-05-08 EP EP06747531A patent/EP2027860A1/en not_active Ceased
- 2006-05-08 EP EP14170573.1A patent/EP2801360B1/en active Active
-
2008
- 2008-09-08 MX MX2008011473A patent/MX2008011473A/es active IP Right Grant
-
2009
- 2009-04-06 US US12/418,993 patent/US20090197921A1/en not_active Abandoned
-
2012
- 2012-06-27 US US13/534,710 patent/US20120270907A1/en not_active Abandoned
-
2015
- 2015-09-22 US US14/860,973 patent/US20160008347A1/en not_active Abandoned
-
2016
- 2016-06-08 US US15/176,555 patent/US20160279116A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009536193A5 (ja) | ||
| WO2007122580A3 (en) | Compositions of phenylephrine useful for treatment of respiratory illness | |
| JP2007522094A5 (ja) | ||
| NO340679B1 (no) | Pyridazinonderivativer, farmasøytiske preparater omfattende slike og slike forbindelser og preparater for anvendelse i terapeutisk aktive substanser til behandling og forebygging av sykdommer | |
| PT2222669E (pt) | Derivados de oxadiazole ativos em esfingosina-1-fosfato (s1p) | |
| JP2007262090A5 (ja) | ||
| RS52169B (en) | STABLE LAKVINIMOD PREPARATIONS | |
| JP2005518433A5 (ja) | ||
| JP2010535814A5 (ja) | ||
| JP2007513165A5 (ja) | ||
| DE602006014990D1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
| MX2009004203A (es) | Combinaciones de paracetamol/ibuprofeno y metodo para su uso. | |
| CL2007002169A1 (es) | Compuestos derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso del compuesto para prevenir o tratar la inflamacion, trastornos urologicos, gastrointestina | |
| JP2010534684A5 (ja) | ||
| DK1931310T3 (da) | Monofasisk filmdannende sammensætning til topisk administration | |
| RS52867B (en) | GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS | |
| DK1781277T3 (da) | Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol | |
| RS53056B (en) | PHARMACEUTICAL PREPARATION CONTAINING (1S) -1,5-ANHYDRO-1- [5- (4-ETHOXYBENZYL) -2-METHOXY-4-METHYLPHENYL] -1-THI-D-GLUCITOL AND METFORMIN AND ITS USE IN THE TREATMENT OF DIABETES | |
| JP2009516719A5 (ja) | ||
| JP2008531710A5 (ja) | ||
| JP2008513426A5 (ja) | ||
| WO2007143163A3 (en) | Pharmaceutical compositions for sustained release of phenyephrine | |
| WO2007095661A8 (en) | Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition | |
| PL2101730T3 (pl) | Postać galenowa do podawania drogą przezśluzkową paracetamolu | |
| JP2008513427A5 (ja) |